Revvity, Inc.has announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow solution for neonatal sequencing, co-developed with Element Biosciences, Inc., a life science company democratizing access to advanced DNA and multi-omic sequencing solutions. This initiative builds upon Revvity's recent introduction of an automated next-generation sequencing (NGS) workflow for newborn sequencing research and strengthens Element’s momentum towards regulatory approval of the benchtop AVITI™ sequencing system...
Pioneering use of artificial intelligence (AI) could cut the time it takes to bring life-saving treatments to patients. This represents just one example of innovation being championed by the UK's seven new regulatory science powerhouses. Innovate UK – the UK’s innovation agency, in partnership with the Medicines and Healthcare products Regulatory Agency (MHRA), Office for Life Sciences, and the Medical Research Council have announced seven Centres of Excellence for Regulatory Science and Innovation...
INTEGRA Biosciences’ WELLJET reagent dispenser now supports API commands based on the SiLA-2 standardized communication protocol for lab automation. This new functionality will make it even easier to integrate the WELLJET into automated laboratory workflows, helping labs to enhance their productivity and reproducibility. Scientists are constantly seeking ways to automate repetitive, time-consuming liquid handling tasks in order to improve their lab’s throughput...
Illumina, Inc., a global leader in DNA sequencing and array-based technologies, has announced a pilot proteomics program to analyze 50,000 UK Biobank samples in collaboration with deCODE Genetics, Standard BioTools, Tecan, GSK, Johnson & Johnson, and Novartis. The pilot program is based on Illumina's upcoming proteomics assay, Illumina Protein Prep™, powered by SOMAmer® technology, a next-generation sequencing (NGS) based solution that will help scale access to proteomic insights...
Leaders from across the region will meet to discuss the advancements in lab technology and the overarching industry, which has seen numerous developments over the past couple of years. With the conference setting its eyes on the evolution of the lab it will address 9 important and varying themes that encompass the breadth of this ever-growing field in Basel, May 27-28...
The Roslin Institute, located on the Easter Bush Campus at the University of Edinburgh’s College of Medicine and Veterinary Medicine, is a thriving hub of innovation in the field of animal biosciences. Research groups hosted by the institute carry out various cutting-edge projects and frequently rely on biological samples, which must be stored at low or ultra-low temperatures (ULT) around the clock to preserve their viability. This article discusses key considerations when choosing cold chain storage solutions for any lab...
London Lab Live 2025 is set to debut on 14–15 May 2025 at ExCeL London, bringing together professionals from across the lab sector to inspire collaboration and innovation. Representing industries such as chemical and material science, FMCG, food and beverage, agriculture, pharma, biotech, medical, real estate, academia, and beyond, the event promises to be the UK’s most dynamic gathering for the lab community...
AMSBIO has implemented a program of investment to support the students at Penn State Lehigh Valley, part of Pennsylvania State University, in their transformative Course-based Undergraduate Research Experience (CURE) program. The CURE program, led by Dr. Jacqueline McLaughlin, allows students to dive into real-world research projects that tackle critical challenges in health and medicine...
Shimadzu Corporation, a pioneer in scientific instrumentation and technology, is proud to announce the celebration of its 150th anniversary. Founded in Kyoto on March 31, 1875, Shimadzu has been at the forefront of innovation and excellence in science and technology for over a century and a half. To commemorate this significant milestone, Shimadzu Corporation has launched a special website today, inviting everyone to join in the celebration...
Thermo Fisher Scientific Inc., the world leader in serving science, has announced the UK Biobank Pharma Proteomics Project (UKB-PPP) has selected its Olink® Explore Platform to support the world’s largest human proteomics study of its kind. UKB-PPP aims to analyze more than 5,400 proteins from 600,000 samples to fuel the discovery of new protein biomarkers that can be used to predict, diagnose and treat diseases...
Leica Biosystems, a global leader in anatomic and digital pathology solutions; and Indica Labs, a global leader in artificial intelligence (AI)-powered digital pathology software, have announced that Leica Biosystems has agreed to make a significant strategic investment in Indica Labs. This partnership has the potential to accelerate AI-enabled companion diagnostics (CDx) and support discoveries and treatments based on discrete or complex biomarker expression profiles which are not discernable by the human eye.
Abselion, an innovator in automated analytical instrumentation that simplifies at-line protein quantification, has secured £6.6 million in Series A financing to bring its award-winning Amperia system to market. This cutting-edge benchtop instrument allows scientists to easily quantify antibodies, AAVs, and other proteins directly from crude samples in as little as one minute, providing critical data on the spot, enhancing efficiency and accuracy in life science research and bioprocessing...
Maximise efficiency and precision in the analysis of monoclonal antibodies (mAbs) and antibody-drug-conjugates (ADCs) with YMC's tailored solutions. This collection of applications combines proven reliability with cutting-edge technologies to optimise your workflows and save valuable lab time. From intact to fragmented mAbs, DAR determination, or native LC-MS techniques, YMC columns provide highly sensitive and reliable methods using ion exchange (IEX), size exclusion (SEC), hydrophobic interaction (HIC), and reversed-phase liquid chromatography (RP)...
Pioneer Group has announced a collaboration agreement with Thermo Fisher Scientific to support biotech founders on their journey towards commercialising intellectual property in the healthcare and sustainability sectors. Through the collaboration, biotech startups based at Pioneer sites across the UK and Ireland, including its new landmark life sciences location at Victoria House in London in partnership with Oxford Properties, will receive access to training, events, technical support, bespoke equipment, and consumables from Thermo Fisher...
Physicists are getting closer to controlling single-molecule chemical reactions – could this shape the future of pharmaceutical research? A new study, published in the prestigious journal Nature Communications, set out to demonstrate for the first time that competing chemical reaction outcomes can be influenced by using the atomic resolution of a scanning tunnelling microscope (STM).
Merck, a leading science and technology company, has signed a definitive agreement with the intention to acquire HUB Organoids Holding B.V. (HUB). Organoids are cell culture models that functionally resemble an organ. They have the potential to speed up drug development, improve understanding of disease treatment in diverse populations, and reduce the industry’s reliance on animal testing. HUB is a pioneer in the field of organoids...
ZEISS partners with Mindpeak, a pioneer in AI-powered pathology solutions, to develop an integrated Multiplex Immunofluorescence (mIF) solution that serves pathologists across research, diagnostics, and clinical applications. Mindpeak’s expertise in AI-based image analysis of pathological tissues, particularly through its established algorithms for clinical routine applications, complements ZEISS's advanced instruments and software for research applications of mIF...
In a new study, published in the journal Nature, researchers from EMBL Barcelona, the University of Texas, the University of Copenhagen, and The Scripps Research Institute have discovered human antibodies that can recognise and target some of the proteins that cause severe malaria. This breakthrough could pave the way for future vaccines or anti-malaria treatments...
AN influential cross-party Lords Committee has written to the Government to raise concerns about its preparedness for future pandemics, describing the current situation as “troubling”. In a letter to Pat McFadden, Chancellor of the Duchy of Lancaster, Baroness Brown of Cambridge, chair of the House of Lords Science and Technology Committee, said experts had raised “troubling concerns about (the UK’s) capacity to manufacture vaccines for future biological threats”...
Conducting quality control analysis in-house can offer time-saving benefits and help to control costs and protect confidential information. However, for companies that are not experienced in selecting an appropriate microscope, outsourcing SEM capabilities to a university or laboratory can be a tempting option. Here, Robbie O’Connell, Sales Account Manager (Electron Microscopy) at SEM specialist Thermo Fisher Scientific, offers advice on what to look for when purchasing an SEM for quality control purposes...
Sapio Sciences, the science-aware™ lab informatics platform, today announced the highly anticipated speaker lineup and agenda for SapioCon 2025. Taking place from February 26–28, 2025, at the Fort Lauderdale Marriott Harbor Beach Resort, the event will bring together leading experts in research and technology to explore the transformative role of AI and science-aware lab informatics in accelerating research, discovery, diagnostics, manufacturing, and business operations in the life sciences.
Azenta, Inc. has announced the launch of a long-read Whole Genome Sequencing (WGS) test for clinical applications. Azenta becomes the first commercial provider to obtain regulatory approval to offer this test in the United States. Traditional short-read sequencing methods often struggle with identifying genetic variants in repetitive regions of the genome that underpin many rare diseases, hindering accurate diagnoses and targeted treatments...
Revvity, Inc.has announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow solution for neonatal sequencing, co-developed with Element Biosciences, Inc., a life science company democratizing access to advanced DNA and multi-omic sequencing solutions. This initiative builds upon Revvity's recent introduction of an automated next-generation sequencing (NGS) workflow for newborn sequencing research and strengthens Element’s momentum towards regulatory approval of the benchtop AVITI™ sequencing system...
Pioneering use of artificial intelligence (AI) could cut the time it takes to bring life-saving treatments to patients. This represents just one example of innovation being championed by the UK's seven new regulatory science powerhouses. Innovate UK – the UK’s innovation agency, in partnership with the Medicines and Healthcare products Regulatory Agency (MHRA), Office for Life Sciences, and the Medical Research Council have announced seven Centres of Excellence for Regulatory Science and Innovation...
INTEGRA Biosciences’ WELLJET reagent dispenser now supports API commands based on the SiLA-2 standardized communication protocol for lab automation. This new functionality will make it even easier to integrate the WELLJET into automated laboratory workflows, helping labs to enhance their productivity and reproducibility. Scientists are constantly seeking ways to automate repetitive, time-consuming liquid handling tasks in order to improve their lab’s throughput...
Illumina, Inc., a global leader in DNA sequencing and array-based technologies, has announced a pilot proteomics program to analyze 50,000 UK Biobank samples in collaboration with deCODE Genetics, Standard BioTools, Tecan, GSK, Johnson & Johnson, and Novartis. The pilot program is based on Illumina's upcoming proteomics assay, Illumina Protein Prep™, powered by SOMAmer® technology, a next-generation sequencing (NGS) based solution that will help scale access to proteomic insights...
Leaders from across the region will meet to discuss the advancements in lab technology and the overarching industry, which has seen numerous developments over the past couple of years. With the conference setting its eyes on the evolution of the lab it will address 9 important and varying themes that encompass the breadth of this ever-growing field in Basel, May 27-28...
The Roslin Institute, located on the Easter Bush Campus at the University of Edinburgh’s College of Medicine and Veterinary Medicine, is a thriving hub of innovation in the field of animal biosciences. Research groups hosted by the institute carry out various cutting-edge projects and frequently rely on biological samples, which must be stored at low or ultra-low temperatures (ULT) around the clock to preserve their viability. This article discusses key considerations when choosing cold chain storage solutions for any lab...
London Lab Live 2025 is set to debut on 14–15 May 2025 at ExCeL London, bringing together professionals from across the lab sector to inspire collaboration and innovation. Representing industries such as chemical and material science, FMCG, food and beverage, agriculture, pharma, biotech, medical, real estate, academia, and beyond, the event promises to be the UK’s most dynamic gathering for the lab community...
AMSBIO has implemented a program of investment to support the students at Penn State Lehigh Valley, part of Pennsylvania State University, in their transformative Course-based Undergraduate Research Experience (CURE) program. The CURE program, led by Dr. Jacqueline McLaughlin, allows students to dive into real-world research projects that tackle critical challenges in health and medicine...
Shimadzu Corporation, a pioneer in scientific instrumentation and technology, is proud to announce the celebration of its 150th anniversary. Founded in Kyoto on March 31, 1875, Shimadzu has been at the forefront of innovation and excellence in science and technology for over a century and a half. To commemorate this significant milestone, Shimadzu Corporation has launched a special website today, inviting everyone to join in the celebration...
Thermo Fisher Scientific Inc., the world leader in serving science, has announced the UK Biobank Pharma Proteomics Project (UKB-PPP) has selected its Olink® Explore Platform to support the world’s largest human proteomics study of its kind. UKB-PPP aims to analyze more than 5,400 proteins from 600,000 samples to fuel the discovery of new protein biomarkers that can be used to predict, diagnose and treat diseases...
Leica Biosystems, a global leader in anatomic and digital pathology solutions; and Indica Labs, a global leader in artificial intelligence (AI)-powered digital pathology software, have announced that Leica Biosystems has agreed to make a significant strategic investment in Indica Labs. This partnership has the potential to accelerate AI-enabled companion diagnostics (CDx) and support discoveries and treatments based on discrete or complex biomarker expression profiles which are not discernable by the human eye.
Abselion, an innovator in automated analytical instrumentation that simplifies at-line protein quantification, has secured £6.6 million in Series A financing to bring its award-winning Amperia system to market. This cutting-edge benchtop instrument allows scientists to easily quantify antibodies, AAVs, and other proteins directly from crude samples in as little as one minute, providing critical data on the spot, enhancing efficiency and accuracy in life science research and bioprocessing...
Maximise efficiency and precision in the analysis of monoclonal antibodies (mAbs) and antibody-drug-conjugates (ADCs) with YMC's tailored solutions. This collection of applications combines proven reliability with cutting-edge technologies to optimise your workflows and save valuable lab time. From intact to fragmented mAbs, DAR determination, or native LC-MS techniques, YMC columns provide highly sensitive and reliable methods using ion exchange (IEX), size exclusion (SEC), hydrophobic interaction (HIC), and reversed-phase liquid chromatography (RP)...
Pioneer Group has announced a collaboration agreement with Thermo Fisher Scientific to support biotech founders on their journey towards commercialising intellectual property in the healthcare and sustainability sectors. Through the collaboration, biotech startups based at Pioneer sites across the UK and Ireland, including its new landmark life sciences location at Victoria House in London in partnership with Oxford Properties, will receive access to training, events, technical support, bespoke equipment, and consumables from Thermo Fisher...
Physicists are getting closer to controlling single-molecule chemical reactions – could this shape the future of pharmaceutical research? A new study, published in the prestigious journal Nature Communications, set out to demonstrate for the first time that competing chemical reaction outcomes can be influenced by using the atomic resolution of a scanning tunnelling microscope (STM).
Merck, a leading science and technology company, has signed a definitive agreement with the intention to acquire HUB Organoids Holding B.V. (HUB). Organoids are cell culture models that functionally resemble an organ. They have the potential to speed up drug development, improve understanding of disease treatment in diverse populations, and reduce the industry’s reliance on animal testing. HUB is a pioneer in the field of organoids...
ZEISS partners with Mindpeak, a pioneer in AI-powered pathology solutions, to develop an integrated Multiplex Immunofluorescence (mIF) solution that serves pathologists across research, diagnostics, and clinical applications. Mindpeak’s expertise in AI-based image analysis of pathological tissues, particularly through its established algorithms for clinical routine applications, complements ZEISS's advanced instruments and software for research applications of mIF...
In a new study, published in the journal Nature, researchers from EMBL Barcelona, the University of Texas, the University of Copenhagen, and The Scripps Research Institute have discovered human antibodies that can recognise and target some of the proteins that cause severe malaria. This breakthrough could pave the way for future vaccines or anti-malaria treatments...
AN influential cross-party Lords Committee has written to the Government to raise concerns about its preparedness for future pandemics, describing the current situation as “troubling”. In a letter to Pat McFadden, Chancellor of the Duchy of Lancaster, Baroness Brown of Cambridge, chair of the House of Lords Science and Technology Committee, said experts had raised “troubling concerns about (the UK’s) capacity to manufacture vaccines for future biological threats”...
Conducting quality control analysis in-house can offer time-saving benefits and help to control costs and protect confidential information. However, for companies that are not experienced in selecting an appropriate microscope, outsourcing SEM capabilities to a university or laboratory can be a tempting option. Here, Robbie O’Connell, Sales Account Manager (Electron Microscopy) at SEM specialist Thermo Fisher Scientific, offers advice on what to look for when purchasing an SEM for quality control purposes...
Sapio Sciences, the science-aware™ lab informatics platform, today announced the highly anticipated speaker lineup and agenda for SapioCon 2025. Taking place from February 26–28, 2025, at the Fort Lauderdale Marriott Harbor Beach Resort, the event will bring together leading experts in research and technology to explore the transformative role of AI and science-aware lab informatics in accelerating research, discovery, diagnostics, manufacturing, and business operations in the life sciences.
Azenta, Inc. has announced the launch of a long-read Whole Genome Sequencing (WGS) test for clinical applications. Azenta becomes the first commercial provider to obtain regulatory approval to offer this test in the United States. Traditional short-read sequencing methods often struggle with identifying genetic variants in repetitive regions of the genome that underpin many rare diseases, hindering accurate diagnoses and targeted treatments...